Skip to main content
SpringerLink
Log in

p53, Deleted in Colorectal Cancer Gene, and Thymidylate Synthase as Predictors of Histopathologic Response and Survival in Low, Locally Advanced Rectal Cancer Treated With Preoperative Adjuvant Therapy

  • Published:
Diseases of the Colon & Rectum

Abstract

PURPOSE: Adjuvant therapy, either preoperatively or postoperatively, and modifications of surgery have been used to try to improve outcome of surgery for rectal cancer in regard to both local recurrence and survival. Assessment of prognosis in patients after resection is currently primarily based on clinicopathologic factors. These predict the subsequent behavior of the tumor only imperfectly. The aim of this study was to evaluate three potential molecular genetic markers of prognosis (p53, deleted in colorectal cancer gene, and thymidylate synthase) in Dukes Stage B and C low rectal tumors treated with adjuvant therapy and to determine whether they correlate with survival, local recurrence, or the pathologic response to adjuvant therapy (assessed by extent of tumor regression and tumor down-staging). METHODS: Sixty locally advanced low rectal tumors resected after preoperative chemoradiotherapy or radiotherapy alone were studied by immunohistochemical staining for p53, deleted in colorectal cancer gene, and thymidylate synthase. In addition, p53 gene mutations were sought by polymerase chain reaction–single-strand conformation polymorphism analysis. These results were correlated with survival, local recurrence, and pathologic response to adjuvant therapy. RESULTS: Lack of thymidylate synthase staining by immunohistochemistry was associated with tumor down-staging after preoperative chemoradiotherapy but not after radiotherapy or for these two combined groups. There was no correlation between p53, deleted in colorectal cancer gene, or thymidylate synthase immunohistochemical staining or between p53 polymerase chain reaction–single-strand conformation polymorphism and local recurrence or survival in locally advanced low rectal cancers treated with preoperative adjuvant therapies. CONCLUSION: Prediction of prognosis in patients with locally advanced low rectal cancers treated with preoperative adjuvant therapies continues to be problematic. Thymidylate synthase immunohistochemistry appears to be the most promising factor of those assessed in predicting tumor down-staging after preoperative chemoradiotherapy for locally advanced low rectal cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. JD Beatty (1992) ArticleTitleImmunotherapy of colorectal cancer Cancer 70 1425–1433

    Google Scholar 

  2. B Cedermark H Johansson LE Rutqvist N Wilking (1995) ArticleTitleThe Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group Cancer 75 2269–2275

    Google Scholar 

  3. FT McDermott ES Hughes E Pihl WR Johnson AB Price (1985) ArticleTitleLocal recurrence after potentially curative resection for rectal cancer in a series of 1008 patients Br J Surg 72 34–37

    Google Scholar 

  4. U Carlsson A Lasson G Ekelund (1987) ArticleTitleRecurrence rates after curative surgery for rectal carcinoma, with special reference to their accuracy Dis Colon Rectum 30 431–434

    Google Scholar 

  5. AW Malcolm NP Perencevich RM Olson JA Hanley JT Chaffey RE Wilson (1981) ArticleTitleAnalysis of recurrence patterns following curative resection for carcinoma of the colon and rectum Surg Gynecol Obstet 152 131–136

    Google Scholar 

  6. L Påhlman (1996) ArticleTitleIncreased five-year survival after preoperative irradiation in rectal cancer Dis Colon Rectum 39 19–136

    Google Scholar 

  7. InstitutionalAuthorNameSwedish Rectal Cancer Trial (1997) ArticleTitleImproved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336 980–987

    Google Scholar 

  8. A Gerard U Metzger M Buyse (1989) ArticleTitleAdjuvant therapy in colorectal cancer Anticancer Res 9 1033–1035

    Google Scholar 

  9. A Horn JF Halvorsen O Dahl (1990) ArticleTitlePreoperative radiotherapy in operable rectal cancer Dis Colon Rectum 33 823–828

    Google Scholar 

  10. T Holm B Cedermark LE Rutqvist (1994) ArticleTitleLocal recurrence of rectal adenocarcinoma after “curative” surgery with and without preoperative radiotherapy Br J Surg 81 452–455

    Google Scholar 

  11. WT Sause TF Pajak RD Noyes et al. (1994) ArticleTitleEvaluation of preoperative radiation therapy in operable colorectal cancer Ann Surg 220 668–675

    Google Scholar 

  12. L Pahlman B Glimelius (1990) ArticleTitlePre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Results from a randomized multicenter trial Ann Surg 211 187–195

    Google Scholar 

  13. CG Moertel DS Childs SuffixJr RJ Reitemeier MY Colby SuffixJr MA Holbrook (1969) ArticleTitleCombined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer Lancet 2 865–867

    Google Scholar 

  14. ET Chen M Mohiuddin H Brodovsky G Fishbein G Marks (1994) ArticleTitleDownstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation Int J Radiat Oncol Biol Phys 30 169–175

    Google Scholar 

  15. A Picciocchi C Coco P Magistrelli et al. (1994) ArticleTitleConcomitant preoperative radiochemotherapy in operable locally advanced rectal cancer Dis Colon Rectum 37 69–72

    Google Scholar 

  16. JE Krook CG Moertel LL Gunderson et al. (1991) ArticleTitleEffective surgical adjuvant therapy for high-risk rectal carcinoma N Engl J Med 324 709–715

    Google Scholar 

  17. V Lingareddy M Mohiuddin G Marks (1994) ArticleTitleThe importance of patient selection for adjunctive postoperative radiation therapy for cancer of the rectum. Patient selection in adjunctive therapy Cancer 73 1805–1810

    Google Scholar 

  18. JW Milsom H Graffner (1990) ArticleTitleIntrarectal ultrasonography in rectal cancer staging and in the evaluation of pelvic disease. Clinical uses of intrarectal ultrasound Ann Surg 212 602–606

    Google Scholar 

  19. WJ Orrom WD Wong DA Rothenberger LL Jensen SM Goldberg (1990) ArticleTitleEndorectal ultrasound in the preoperative staging of rectal tumours. A learning experience Dis Colon Rectum 33 654–659

    Google Scholar 

  20. MJ Solomon RS McLeod (1993) ArticleTitleEndoluminal transrectal ultrasonography Dis Colon Rectum 36 200–205

    Google Scholar 

  21. MJ Solomon RS McLeod EK Cohen ME Simons S Wilson (1994) ArticleTitleReliability and validity studies of endoluminal ultrasonography for anorectal disorders Dis Colon Rectum 37 546–551

    Google Scholar 

  23. CG Fu O Tominaga H Nagawa et al. (1998) ArticleTitleRole of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients Dis Colon Rectum 41 68–74

    Google Scholar 

  24. S Levi A Urbano-Ispizua R Gill et al. (1991) ArticleTitleMultiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique Cancer Res 51 3497–3502

    Google Scholar 

  25. B Dix P Robbins S Carrello A House B Iacopetta (1994) ArticleTitleComparison of p53 gene mutation and protein overexpression in colorectal carcinomas Br J Cancer 70 585–590

    Google Scholar 

  26. B Budowle R Chakraborty AM Giusti AJ Eisenberg RC Allen (1991) ArticleTitleAnalysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE Am J Hum Genet 48 137–144

    Google Scholar 

  27. AM Mandard F Dalibard JC Mandard et al. (1994) ArticleTitlePathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations Cancer 73 2680–2686

    Google Scholar 

  28. MJ Morgan DJ Koorey D Painter et al. (2002) ArticleTitleHistological tumour response to pre-operative combined modality therapy in locally advanced rectal cancer Colorectal Dis 4 177–183

    Google Scholar 

  29. PG Johnston ER Fisher HE Rockette et al. (1994) ArticleTitleThe role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer J Clin Oncol 12 2640–2647

    Google Scholar 

  30. HJ Lenz K Hayashi D Salonga et al. (1998) ArticleTitlep53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer Clin Cancer Res 4 1243–1250

    Google Scholar 

  31. T Yamachika H Nakanishi K Inada et al. (1998) ArticleTitleA new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance Cancer 82 70–77

    Google Scholar 

  32. B van Triest HM Pinedo Y van Hensbergen et al. (1999) ArticleTitleThymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines Clin Cancer Res 5 643–654

    Google Scholar 

  33. D Edler M Hallstrom PG Johnston I Magnusson P Ragnhammar H Blomgren (2000) ArticleTitleThymidylate synthase expression Clin Cancer Res 6 1378–1384

    Google Scholar 

  34. A Okonkwo S Musunuri M Talamonti et al. (2001) ArticleTitleMolecular markers and prediction of response to chemoradiation in rectal cancer Oncol Rep 8 497–500

    Google Scholar 

  35. TA Rich JM Skibber JA Ajani et al. (1995) ArticleTitlePreoperative infusional chemoradiation therapy for stage T3 rectal cancer Int J Radiat Oncol Biol Phys 32 1025–1029

    Google Scholar 

  36. Y Remvikos O Tominaga P Hammel et al. (1992) ArticleTitleIncreased p53 protein content of colorectal tumours correlates with poor survival Br J Cancer 66 758–764

    Google Scholar 

  37. R Hamelin P Laurent-Puig S Olschwang et al. (1994) ArticleTitleAssociation of p53 mutations with short survival in colorectal cancer Gastroenterology 106 42–48

    Google Scholar 

  38. A Yamaguchi Y Kurosaka S Fushida et al. (1992) ArticleTitleExpression of p53 protein in colorectal cancer and its relationship to short-term prognosis Cancer 70 2778–2784

    Google Scholar 

  39. DT Leahy R Salman H Mulcahy K Sheahan DP O’Donoghue NA Parfrey (1996) ArticleTitlePrognostic significance of p53 abnormalities in colorectal carcinoma detected by PCR-SSCP and immunohistochemical analysis J Pathol 180 364–370

    Google Scholar 

  40. A Auvinen J Isola T Visakorpi T Koivula S Virtanen M Hakama (1994) ArticleTitleOverexpression of p53 and long-term survival in colon carcinoma Br J Cancer 70 293–296

    Google Scholar 

  41. G Adell XF Sun O Stal C Klintenberg R Sjodahl B Nordenskjold (1999) ArticleTitlep53 status Radiother Oncol 51 169–174

    Google Scholar 

  42. R Wiggenraad R Taminga P Blok R Rouse J Hermans (1998) ArticleTitleThe prognostic significance of p53 expression for survival and local control in rectal cancer treated with surgery and postoperative radiotherapy Int J Radiat Oncol Biol Phys 41 29–35

    Google Scholar 

  43. H Elsaleh P Robbins D Joseph et al. (2000) ArticleTitleCan p53 alterations be used to predict tumour response to pre-operative chemo-radiotherapy in locally advanced rectal cancer? Radiother Oncol 56 239–244

    Google Scholar 

  44. FR Spitz GG Giacco K Hess et al. (1997) ArticleTitlep53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer Clin Cancer Res 3 1685–1690

    Google Scholar 

  45. PG Meade GJ Blatchford AG Thorson MA Christensen CA Ternent (1995) ArticleTitlePreoperative chemoradiation downstages locally advanced ultrasound-staged rectal cancer Am J Surg 170 609–613

    Google Scholar 

  46. S Meterissian J Skibber T Rich et al. (1994) ArticleTitlePatterns of residual disease after preoperative chemoradiation in ultrasound T3 rectal carcinoma Ann Surg Oncol 1 111–116

    Google Scholar 

  47. JC Landry MJ Koretz WC Wood et al. (1993) ArticleTitlePreoperative irradiation and fluorouracil chemotherapy for locally advanced rectosigmoid carcinoma Radiology 188 423–426

    Google Scholar 

  48. JF Bosset JJ Pavy HP Hamers et al. (1993) ArticleTitleDetermination of the optimal dose of 5-fluorouracil when combined with low dose D,L-leucovorin and irradiation in rectal cancer: results of three consecutive phase II studies. EORTC Radiotherapy Group Eur J Cancer 29 1406–1410

    Google Scholar 

  49. M Fritsche C Haessler G Brandner (1993) ArticleTitleInduction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents Oncogene 8 307–318

    Google Scholar 

  50. P Iniesta FJ Vega T Caldes et al. (1998) ArticleTitlep53 exon 7 mutations as a predictor of poor prognosis in patients with colorectal cancer Cancer Lett 130 153–160

    Google Scholar 

  51. T Caldes P Iniesta FJ Vega et al. (1998) ArticleTitleComparative survival analysis of p53 gene mutations and protein accumulation in colorectal cancer Oncology 55 249–257

    Google Scholar 

  52. AJ Klingelhutz L Hedrick KR Cho JK McDougall (1995) ArticleTitleThe DCC gene suppresses the malignant phenotype of transformed human epithelial cells Oncogene 10 1581–1586

    Google Scholar 

  53. D Shibata MA Reale P Lavin et al. (1996) ArticleTitleThe DCC protein and prognosis in colorectal cancer N Engl J Med 335 1727–1732

    Google Scholar 

  54. MA Reymond O Dworak S Remke W Hohenberger T Kirchner F Kocherling (1998) ArticleTitleDCC protein as a predictor of distant metastases after curative surgery for rectal cancer Dis Colon Rectum 41 755–760

    Google Scholar 

  55. IO Baas JW Mulder GJ Offerhaus B Vogelstein SR Hamilton (1994) ArticleTitleAn evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms J Pathol 172 5–12

    Google Scholar 

  56. SM Bell N Scott D Cross et al. (1993) ArticleTitlePrognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer Gastroenterology 104 57–64

    Google Scholar 

  57. DJ Ahnen P Feigl G Quan et al. (1998) ArticleTitleKi-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer Cancer Res 58 1149–1158

    Google Scholar 

  58. GT Deans TG Parks BJ Rowlands RA Spence (1992) ArticleTitlePrognostic factors in colorectal cancer Br J Surg 79 608–613

    Google Scholar 

  59. VB Astler FA Coller (1954) ArticleTitleThe prognostic significance of direct extension of carcinoma of the colon and rectum Ann Surg 139 846–852

    Google Scholar 

  60. CE Dukes HJ Bussey (1958) ArticleTitleThe spread of rectal cancer and its effect on prognosis Br J Cancer 12 209–220

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Surgery, Gastroenterology, Anatomical Pathology, Medical Oncology, and Radiation Oncology, Royal Prince Alfred Hospital, Department of Surgery, Concord Hospital, and Department of Surgery, University of Sydney, Sydney, Australia

    Robyn P. M. Saw M.S., F.R.A.C.S., Matthew Morgan M.S., F.R.A.C.S., David Koorey Ph.D., F.R.A.C.P., Dorothy Painter F.R.C.P.A., Michael Findlay M.D., F.R.A.C.P., Graham Stevens M.D., F.R.A.N.Z.C.R., Stephen Clarke Ph.D., F.R.A.C.P., Pierre Chapuis D.S., F.R.A.C.S. & Michael J. Solomon M.Sc., F.R.A.C.S.

Authors
  1. Robyn P. M. Saw M.S., F.R.A.C.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthew Morgan M.S., F.R.A.C.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David Koorey Ph.D., F.R.A.C.P.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dorothy Painter F.R.C.P.A.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael Findlay M.D., F.R.A.C.P.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Graham Stevens M.D., F.R.A.N.Z.C.R.
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stephen Clarke Ph.D., F.R.A.C.P.
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Pierre Chapuis D.S., F.R.A.C.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Michael J. Solomon M.Sc., F.R.A.C.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Saw, R.P., Morgan, M., Koorey, D. et al. p53, Deleted in Colorectal Cancer Gene, and Thymidylate Synthase as Predictors of Histopathologic Response and Survival in Low, Locally Advanced Rectal Cancer Treated With Preoperative Adjuvant Therapy. Dis Colon Rectum 46, 192–202 (2003). https://doi.org/10.1007/s10350-004-6524-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10350-004-6524-2

Keywords

Search

Navigation